Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Farxiga and Weight Loss

Share Post:

What is Farxiga (Dapagliflozin)?

Farxiga also known as dapagliflozin is an oral drug that helps to lower blood sugar levels in diabetic patients. This is achieved by helping your body to filter excess sugar out of the blood. Dapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. SGLT2 proteins are responsible for 90 percent of sugar that is reabsorbed into the bloodstream. The medication allows sugar in the bloodstream to be removed by the kidney and excreted via urine, by inhibiting SGLT2 proteins. Forxiga should not be used to treat type 1 diabetes, a medical condition where the body does not produce any insulin. Note that this medicine is part of a medication treatment program that includes exercise, diet, regular blood sugar testing and weight control.

Does Farxiga help with weight loss?

Many people want to use farxiga to reduce weight even if they don’t have diabetes. However, how rapid is weight loss with Farxiga can vary from person to person. The drug is not yet approved for weight loss. Moreover, this medication will have less effect on weight in people with normal blood sugar, since less glucose will leak into the urine. However, a recent study showed that dapagliflozin helps type 2 diabetic patients lose a few pounds in addition to lowering blood glucose levels. The study showed that dapagliflozin leads to a loss of fat mass, with major reductions in both subcutaneous adipose tissue and abdominal visceral adipose tissue. Even though trials showed that dapagliflozin can lead to moderate weight loss, the exact figure of the pounds lost remains largely unknown.

Doctor’s Recommendation

Do not take Farxiga for weight loss because the weight loss is mainly due to urinating more water and glucose out of the body. Some long-term modest weight loss may be theoretically possible due to urinating the calories from excess glucose, but this is not a substantial enough amount to be considered a factor in the risk-benefit analysis.


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on April 23, 2021

Related Products

Dapagliflozin
  • In Stock
  • Express Shipping

Related Articles

Diabetes, Diabetes Supplies,
Large Scale Real World Evidence Ozempic Actually Reduces Suicide: Debunked Unfounded Concerns

In recent years, Semaglutide has emerged as a groundbreaking medication for managing type 2 diabetes and aiding weight loss in individuals with obesity. Marketed under brand names like Ozempic and…

Read More
Weight Loss
Wegovy Weight Loss: A Breakthrough in Weight Management

Losing weight can be daunting. For many, diet and exercise alone may not be enough to achieve long-term success. With new advancements in medical weight management, individuals struggling with obesity…

Read More
Diabetes, Diabetes Supplies,
Best Large Scale Evidence that Ozempic May Reduce All Cause Mortality in Individuals with Chronic Kidney Disease

Discover how semaglutide may reduce the risk of kidney failure and heart complications in individuals with type 2 diabetes and chronic kidney disease.Type 2 diabetes and chronic kidney disease (CKD)…

Read More
Cardiovascular Health, Diabetes,
Dapagliflozin: Best for Heart Failure With High Pressure Flow-Based on Real World Data

Understanding Heart Failure and Its ImpactHeart failure (HF) is a chronic condition affecting over 26 million people worldwide. It occurs when the heart can’t pump enough blood to meet the…

Read More